Michael H. Davidson

Companies

• BioAge Labs, Inc.Board member Sep 25, 2024 to now¹
• NewAmsterdam Pharma Co N.V.Board member Dec 29, 2023 to now²
• NewAmsterdam Pharma Co N.V.Chief executive officer Dec 29, 2023 to now²
• TENAX THERAPEUTICS, INC.Board member Jun 15, 2021 to now³
• Silence TherapeuticsBoard member Jan 2, 2025 to Jan 6, 2025⁴
• Caladrius BiosciencesBoard member Aug 12, 2020 to Jan 12, 2022⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NPNewAmsterdam Pharma Co N.V. NAMS1,078,638 shares⁶$21.9M at $20.29Sep 15, 2026
• STSilence Therapeutics SLN12,993 shares⁷$254.3K at $19.57Jan 2, 2025
• CBCaladrius Biosciences LSTA209,753 shares⁸$205.6K at $0.98Jan 10, 2022
• TTTENAX THERAPEUTICS, INC. TENX2,881 shares⁹$4.4K at $1.52Jan 13, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 14, 2026Bought 10,000 shares at $22.65 of NewAmsterdam Pharma Co N.V.⁶
• Mar 2, 2026Sold 443,707 shares at $33.25 of NewAmsterdam Pharma Co N.V.¹⁰
• Mar 2, 2026Exercised options 443,707 shares of NewAmsterdam Pharma Co N.V.¹⁰
• Feb 26, 2026Sold 17,924 shares at $34.44 of NewAmsterdam Pharma Co N.V.¹¹
• Feb 26, 2026Sold 165,408 shares at $33.63 of NewAmsterdam Pharma Co N.V.¹¹
• Feb 26, 2026Exercised options 183,332 shares of NewAmsterdam Pharma Co N.V.¹¹
• Feb 25, 2026Sold 1,300 shares at $36.68 of NewAmsterdam Pharma Co N.V.¹¹
• Feb 25, 2026Sold 10,436 shares at $35.96 of NewAmsterdam Pharma Co N.V.¹¹
• Feb 25, 2026Sold 46,517 shares at $35.11 of NewAmsterdam Pharma Co N.V.¹¹
• Feb 25, 2026Exercised options 58,253 shares of NewAmsterdam Pharma Co N.V.¹¹
• Feb 24, 2026Sold 3,161 shares at $36.46 of NewAmsterdam Pharma Co N.V.¹¹
• Feb 24, 2026Sold 61,547 shares at $36.13 of NewAmsterdam Pharma Co N.V.¹¹
• Feb 24, 2026Exercised options 64,708 shares of NewAmsterdam Pharma Co N.V.¹¹
• Jan 7, 2026Granted 81,000 shares of NewAmsterdam Pharma Co N.V.¹²
• Jan 7, 2026Sold 11,582 shares of NewAmsterdam Pharma Co N.V.¹²
• Mar 26, 2025Sold 12,258 shares of NewAmsterdam Pharma Co N.V.¹³
• Mar 26, 2025Exercised options 38,394 shares of NewAmsterdam Pharma Co N.V.¹³
• Mar 26, 2025Granted 30,992 shares of NewAmsterdam Pharma Co N.V.¹³
• Jan 7, 2025Granted 123,529 shares of NewAmsterdam Pharma Co N.V.¹⁴
• Aug 20, 2024Bought 5,000 shares at $16.27 of NewAmsterdam Pharma Co N.V.¹⁵
• Aug 8, 2024Bought 2,500 shares of TENAX THERAPEUTICS, INC.¹⁶
• Jun 20, 2024Bought 5,000 shares at $17.26 of NewAmsterdam Pharma Co N.V.¹⁷
• Jan 10, 2022Granted 65,430 shares of Caladrius Biosciences⁸